Full Breakdown
Campaigners Demand Andy Burnham Reverse UK-US Drug Deal and Privatization Measures
7/10/2026, 4:04:05 PM
Campaigners Urge Burnham to Scrap the UK-US Medicines Agreement
A coalition of 19 health-focused organisations, including Medact, the Doctors’ Association UK and Doctors in Unite, sent an open letter to Andy Burnham—widely tipped to become Labour leader and prime minister—calling for an immediate “decisive break” with the trade deal on medicines signed last December. The signatories argue the agreement obliges the NHS to spend an estimated £44.7 billion (or roughly £45 billion) on higher-priced drugs by 2036, diverting funds from essential services and risking hundreds of thousands of avoidable deaths.
Background: Funding Strain, PFI Projects and Data Contracts
Over the past 15 years the NHS has faced successive cuts, under-funding and the expansion of private-sector involvement. Campaigners cite a new wave of Private Finance Initiative (PFI) contracts for neighbourhood health centres, recent job cuts across English hospitals, and the rollout of a Palantir data-management system—described as a “human rights abusing corporation”—as further threats to publicly delivered care. They contend that these policies, combined with the drug deal, could force the service “on life support.”
Who Is Speaking: Organisations and Leaders
The letter was signed by doctors, nurses, firefighters, teachers, pensioners and disabled people, representing a broad cross-section of ordinary workers. Dr Tony O’Sullivan, co-chair of Keep Our NHS Public and retired consultant paediatrician, highlighted the financial impact of the deal. Hope Worsdale, a spokesperson for the patient group Just Treatment, echoed the urgency of protecting the NHS from corporate profit-driven policies.
Official Responses & Government Position
Health ministers have defended the agreement as a means to boost British drug exports to the United States and to give patients access to new medicines that might otherwise be blocked by tariffs. No comment was obtained from Burnham on whether he intends to repeal the deal or renegotiate its terms.
Conflicting Estimates & Gaps
Analyses by academics from the University of York, the University of Liverpool and Christchurch Hospital (New Zealand) project 229 000 excess deaths by 2036 due to the deal’s cost pressures, while a Guardian report earlier cited “more than 200 000 avoidable patient deaths.” Both figures underscore the uncertainty surrounding the precise mortality impact. No independent audit of the deal’s financial terms has been released, leaving a gap in publicly verifiable data.
- “Donald Trump’s demands for higher drug prices are set to drain an estimated £45bn from the NHS over the next decade. At a time when patients are waiting longer than ever for treatment, handing over billions more to US pharmaceutical giants is like trying to put out a fire while pouring petrol on the flames.” — Dr Tony O’Sullivan, Co-chair, Keep Our NHS Public
- “The NHS is already on life support. Every year, around 16,000 people die unnecessarily because of delays in emergency care, maternity services continue to fail families, and millions are stuck on waiting lists. The last thing the NHS needs is to be forced to bankroll bigger profits for multinational drug companies.” — Hope Worsdale, Just Treatment
- “We are asking Andy Burnham to meet with campaigners and listen to those with deep experience of the NHS and social care. His transition into government is a chance to draw a line under policies that have put corporate interests ahead of patients, restore public trust and staff morale, and recognise that health, care and education are the foundations of a thriving society and economy.” — Letter to Burnham (SOS NHS coalition)
- “tens of thousands of patients needlessly losing their lives and burnt-out staff leaving faster than they can be replaced.” — Open letter to Andy Burnham (campaign coalition)
